Showing results (91-100 of 233) with videos related to
Sort By:
Pageof 24
Blood Advances|January 29, 2020
Long-term outcomes after autologous stem cell transplantation for multiple myelomaKatherine K Nishimura, Bart Barlogie, Frits van Rhee, et al.Blood Advances|July 21, 2026
Efficacy and Safety of BCMA-Targeted Therapies in Relapsed or Refractory AL Amyloidosis: A Descriptive Pooled AnalysisRaghad Alqazaqi, Sean Taasan, William Schwartzman, et al.Haematologica|September 4, 2025
The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site studyMichael A Bauer, Phillip Farmer, Joseph L Su, et al.American Journal of Hematology|April 21, 2018
Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman diseaseSheila K Pierson, Aaron J Stonestrom, Dustin Shilling, et al.Haematologica|June 13, 2012
Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agentsSaad Z Usmani, Christoph Heuck, Alan Mitchell, et al.Immunotherapy|February 19, 2016
Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?Sharmilan Thanendrarajan, Faith E Davies, Gareth J Morgan, et al.Nature Communications|November 26, 2022
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman diseaseSheila K Pierson, Laura Katz, Reece Williams, et al.Vaccine|January 11, 2014
Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vectorRamesh B Batchu, Oksana V Gruzdyn, Amberly M Moreno-Bost, et al.The Lancet. Haematology|April 12, 2016
Idiopathic multicentric Castleman's disease: a systematic literature reviewAmy Y Liu, Christopher S Nabel, Brian S Finkelman, et al.Clinical Case Reports|April 4, 2015
Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocolsZeba N Singh, Yogesh Jethava, Ginell R Post, et al.Pageof 24